Literature DB >> 25689105

Tumourigenic canine osteosarcoma cell lines associated with frizzled-6 up-regulation and enhanced side population cell frequency.

L C de Sá Rodrigues1, K E Holmes1, V Thompson1, M A Newton2,3, T J Stein1,3,4.   

Abstract

An increased serum alkaline phosphatase concentration is known to be associated with a negative prognosis in canine and human osteosarcoma. To expand upon previous studies regarding the biological relevance of increased serum alkaline phosphatase as a negative prognostic factor, xenogeneic heterotopic transplants were performed using six canine primary osteosarcoma cell lines generated from patients with differing serum alkaline phosphatase concentrations (three normal and three increased). Three of the six cell lines were capable of generating tumours and tumour formation was independent of the serum alkaline phosphatase status of the cell line. Microarray analysis identified 379 genes as being differentially expressed between the tumourigenic and non-tumourigenic cell lines. Frizzled-6 was upregulated to the greatest extent (7.78-fold) in tumourigenic cell lines compared with non-tumourigenic cell lines. Frizzled-6, a co-receptor for Wnt ligands has been associated with enhanced tumour-initiating cells and poor prognosis for other tumours. The increased expression of frizzled-6 was confirmed by quantitative reverse transcription polymerase chain reaction (QPCR) and Western blot analysis. Additionally, the tumourigenic cell lines also had an increase in the percentage of side population cells compared with non-tumourigenic cell lines (5.89% versus 1.58%, respectively). There were no differences in tumourigenicity, frizzled-6 or percentage of side population cells noted between osteosarcoma cell lines generated from patients of differing serum alkaline phosphatase concentration. However, to our knowledge this is the first study to identified frizzled-6 as a possible marker of osteosarcoma cell populations with enhanced tumourigenicity and side population cells. Future work will focus on defining the role of frizzled-6 in osteosarcoma tumourigenesis and tumour-initiating cells.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  cell signalling; comparative oncology; mouse models; oncology; tumour biology

Mesh:

Substances:

Year:  2015        PMID: 25689105      PMCID: PMC4841762          DOI: 10.1111/vco.12138

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  30 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Metastasis-associated differences in gene expression in a murine model of osteosarcoma.

Authors:  C Khanna; J Khan; P Nguyen; J Prehn; J Caylor; C Yeung; J Trepel; P Meltzer; L Helman
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

Review 3.  The spliceosome: design principles of a dynamic RNP machine.

Authors:  Markus C Wahl; Cindy L Will; Reinhard Lührmann
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

4.  Prognostic significance of serum alkaline phosphatase activity in canine appendicular osteosarcoma.

Authors:  C K Garzotto; J Berg; W E Hoffmann; W M Rand
Journal:  J Vet Intern Med       Date:  2000 Nov-Dec       Impact factor: 3.333

5.  Dysregulation of Frizzled 6 is a critical component of B-cell leukemogenesis in a mouse model of chronic lymphocytic leukemia.

Authors:  Qing-Li Wu; Claudia Zierold; Erik A Ranheim
Journal:  Blood       Date:  2009-01-28       Impact factor: 22.113

6.  Canine osteosarcoma cell lines from patients with differing serum alkaline phosphatase concentrations display no behavioural differences in vitro.

Authors:  K E Holmes; V Thompson; C M Piskun; R A Kohnken; M K Huelsmeyer; T M Fan; T J Stein
Journal:  Vet Comp Oncol       Date:  2013-03-12       Impact factor: 2.613

7.  Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs.

Authors:  Brenda Phillips; Barbara E Powers; William S Dernell; Rod C Straw; Chand Khanna; Gary S Hogge; David M Vail
Journal:  J Am Anim Hosp Assoc       Date:  2009 Jan-Feb       Impact factor: 1.023

8.  Association between absolute tumor burden and serum bone-specific alkaline phosphatase in canine appendicular osteosarcoma.

Authors:  R A Sternberg; H C Pondenis; X Yang; M A Mitchell; R T O'Brien; L D Garrett; W G Helferich; W E Hoffmann; T M Fan
Journal:  J Vet Intern Med       Date:  2013-06-04       Impact factor: 3.333

9.  Prognostic importance of alkaline phosphatase activity in serum from dogs with appendicular osteosarcoma: 75 cases (1990-1996).

Authors:  N Ehrhart; W S Dernell; W E Hoffmann; R M Weigel; B E Powers; S J Withrow
Journal:  J Am Vet Med Assoc       Date:  1998-10-01       Impact factor: 1.936

10.  From genomics to chemical genomics: new developments in KEGG.

Authors:  Minoru Kanehisa; Susumu Goto; Masahiro Hattori; Kiyoko F Aoki-Kinoshita; Masumi Itoh; Shuichi Kawashima; Toshiaki Katayama; Michihiro Araki; Mika Hirakawa
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

View more
  4 in total

Review 1.  Canine sarcomas as a surrogate for the human disease.

Authors:  Daniel L Gustafson; Dawn L Duval; Daniel P Regan; Douglas H Thamm
Journal:  Pharmacol Ther       Date:  2018-03-09       Impact factor: 12.310

2.  The Association of Endothelin-1 Signaling with Bone Alkaline Phosphatase Expression and Protumorigenic Activities in Canine Osteosarcoma.

Authors:  Z L Neumann; H C Pondenis; A Masyr; M L Byrum; K L Wycislo; T M Fan
Journal:  J Vet Intern Med       Date:  2015-10-01       Impact factor: 3.333

3.  The Prognostic Value of the Developmental Gene FZD6 in Young Saudi Breast Cancer Patients: A Biomarkers Discovery and Cancer Inducers OncoScreen Approach.

Authors:  Mourad Assidi; Abdelbaset Buhmeida; Maryam H Al-Zahrani; Jaudah Al-Maghrabi; Mahmood Rasool; Muhammad I Naseer; Heba Alkhatabi; Abdulmajeed F Alrefaei; Ali Zari; Razan Elkhatib; Adel Abuzenadah; Peter N Pushparaj; Muhammad Abu-Elmagd
Journal:  Front Mol Biosci       Date:  2022-02-14

4.  A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma.

Authors:  Faezeh Ajorloo; Mohammad Vaezi; Alireza Saadat; Seyed Reza Safaee; Behrouz Gharib; Mostafa Ghanei; Seyed Davar Siadat; Farzam Vaziri; Abolfazl Fateh; Mehrdad Pazhouhandeh; Behrouz Vaziri; Reza Moazemi; Fereidoun Mahboudi; Fatemeh Rahimi Jamnani
Journal:  PLoS One       Date:  2017-09-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.